Impact of EGFR amplification on survival of patients with EGFR exon 20 insertion-positive non-small cell lung cancer

BACKGROUND: Epidermal growth factor receptor (EGFR) exon 20 insertion (EGFR ex20ins) is a common mutation in non-small cell lung cancer (NSCLC). Patients with EGFR ex20ins generally respond poor to EGFR-tyrosine kinase inhibitors (EGFR-TKIs). EGFR ex20ins are often co-occurring with EGFR amplificati...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Xin, Wei, Xue-Wu, Zheng, Ming-Ying, Chen, Zhi-Hong, Zhang, Xu-Chao, Zhong, Wen-Zhao, Yang, Jin-Ji, Wu, Yi-Long, Zhou, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656444/
https://www.ncbi.nlm.nih.gov/pubmed/33209414
http://dx.doi.org/10.21037/jtd-20-1630

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7656444/
https://www.ncbi.nlm.nih.gov/pubmed/33209414
http://dx.doi.org/10.21037/jtd-20-1630

Ejemplares similares